Semaglutide Recall: Nomida Lot 241113 and Lot 250103
Announced 2026-03-11 · FDA
The FDA recall affects New Life Pharma LLC Semaglutide Inj, 2 mg, Sterile Multi-Dose Vial, Rx only, distributed in Ohio, due to lack of assurance of sterility. Affected lots are Lot 241113 (exp 11/30/2026) and Lot 250103 (exp 1/31/2027); total 820 vials were involved. No corrective action is specified in the provided information.
| Brand | New Life Pharma LLC |
|---|---|
| Product | Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07. |
| Reason | Lack of Assurance of Sterility |
| Severity | moderate |
| Units affected | 2 |
| Distribution | OH |
| Agency | FDA |
| Recall / campaign no. | Lot 241113, Exp Date 11/30/2026 & Lot 250103, Exp Date 1/31/2027 |
WHAT YOU SHOULD DO
- Do not use any recalled Semaglutide vials (Lot 241113 or Lot 250103).
- Contact your healthcare provider or dispensing pharmacy for guidance and replacement options.
- Return or dispose of the recalled vials per the pharmacy or manufacturer’s instructions.
- If you have experienced problems, report them to your healthcare provider or FDA MedWatch.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.